Zoltan Ivics
Paul Ehrlich Str. 51-59
Langen, NI 63225, Germany
Langen, NI 63225, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 150 publications
Non-viral vectors as beacons of hope for reducing genotoxic risks of gene therapy.
Journal: Nature biomedical engineering
Published: January 06, 2026
Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignances.
Journal: Molecular therapy. Methods & clinical development
Published: October 15, 2024
The best of both worlds: AAV-mediated gene transfer empowered by LNP delivery of Sleeping Beauty transposase for durable transgene expression in vivo.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 15, 2024
A novel hyperactive variant of the Sleeping Beauty transposase facilitates non-viral genome engineering.
Journal: Molecular therapy. Nucleic acids
Published: July 02, 2024
An LNP-CRISPR gene editing drug demonstrates efficacy and safety in patients with hereditary angioedema following in vivo administration.
Journal: The Journal of allergy and clinical immunology
Published: April 09, 2024
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 23, 2024
Spatiotemporal analysis of SARS-CoV-2 infection reveals an expansive wave of monocyte-derived macrophages associated with vascular damage and virus clearance in hamster lungs.
Journal: Microbiology spectrum
Published: November 27, 2023
DNA binding and transposition activity of the Sleeping Beauty transposase: role of structural stability of the primary DNA-binding domain.
Journal: Nucleic acids research
Published: September 24, 2023
Generation of four gene-edited human induced pluripotent stem cell lines with mutations in the ATM gene to model Ataxia-Telangiectasia.
Journal: Stem cell research
Published: September 18, 2023
Erratum: Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells.
Journal: Molecular therapy oncolytics
Published: September 01, 2023
Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations.
Journal: Frontiers in immunology
Published: August 21, 2023
Last Updated: 09/26/2026